Sea Otter Advisors’s Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share VHAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-200,000
Closed -$5.2K 263
2023
Q3
$5.2K Hold
200,000
﹤0.01% 199
2023
Q2
$4.02K Hold
200,000
﹤0.01% 209
2023
Q1
$3K Hold
200,000
﹤0.01% 228
2022
Q4
$10K Buy
+200,000
New +$11K 0.01% 70

Other funds holding VHAQ.WS

Sea Otter Advisors's VHAQ.WS Position: Q4 2023 in Review

Sea Otter Advisors sold out of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) in Q4 2023, closing a stake of 200,000 shares — an estimated $5.2K sold.

Sea Otter Advisors first reported a position in VHAQ.WS in Q4 2022 and held it in 4 quarters. The position peaked at $10K in Q4 2022. 6 funds tracked by Wall St. Rank hold VHAQ.WS as of Q4 2023.

  • Sea Otter Advisors reported no remaining Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position as of Q4 2023 after selling out during the quarter.
  • Sea Otter Advisors sold 200,000 Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share shares in Q4 2023, an estimated $5.2K.
  • Sea Otter Advisors first reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in Q4 2022 and held it in 4 quarters.
  • Sea Otter Advisors's Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position peaked at $10K in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share as of Q4 2023.

Based on Sea Otter Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.